Extended therapy with [ 177 Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer.

Nicolai MaderChristina Nguyen NgocBilge KirkgözeJustus BaumgartenDaniel GroenerKonrad KlimekChristian HappelNikolaos TselisFelix K H ChunFrank GrünwaldAmir Sabet

Published in: European journal of nuclear medicine and molecular imaging (2023)

Lu]Lu-PSMA-617. Improved survival and the acceptable safety profile warrant further investigation of the concept of additional cycles in selected patients.

Keyphrases

pet ct
end stage renal disease
newly diagnosed
pet imaging
ejection fraction
small cell lung cancer
squamous cell carcinoma
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
patient reported outcomes
computed tomography
patient reported